Topic
14 research guides on ray peat bioenergetic.
Vitamin K in the bioenergetic-research framework - K1 vs K2 (MK-4 vs MK-7), mitochondrial electron carrier function, cardiovascular and bone research, and the case for K2 (MK-4) as the bioenergetic protocol form. Pairing with slow-release T3.
The complete 2026 research guide to the Ray Peat protocol - the bioenergetic framework that pairs slow-release T3, anti-serotonin compounds, pregnenolone and progesterone, methylene blue, and a metabolic-rate-supportive diet. Mechanism, compounds, controversies (including the fasting debate), and how the framework integrates with modern T3+T2 research.
A careful re-examination of Ray Peat's anti-fasting argument with the missing piece - 3,5-T2 and the mitochondrial mechanism Peat's framework predates. Where Peat's cortisol argument holds, where T3 replacement modifies it, and where T2 supplementation reframes it entirely.
The Ray Peat-aligned thyroid stack the bioenergetic-research community converges on - sustained-release T3 plus 3,5-T2 plus cyproheptadine - explained from mechanism to sourcing. Why each component matters, how they integrate, and where to find research-grade reference standards with clean excipient profiles.
Progesterone's mechanism in the bioenergetic-research framework - GABAergic, anti-estrogenic, thyroid-supportive - and the research context for its use alongside slow-release T3. Mechanism, dose ranges, oral vs topical bioavailability, and the Ray Peat-aligned protocol context.
The 2026 research primer on pregnenolone - the parent steroid the bioenergetic-research community uses as the adrenal-axis support layer paired with thyroid hormone. Mechanism, downstream metabolites (progesterone, DHEA, cortisol), dose ranges, safety profile, and the Ray Peat context.
Pansterone-style pregnenolone + DHEA stacks are widely discussed in bioenergetic-research forums. A research-context look at the components, the stacking rationale, dose ranges, downstream metabolism, and the broader Ray Peat-aligned protocol context. Pairing with slow-release T3.
The complete research guide to niacinamide (vs niacin) in the bioenergetic-research framework. NAD+ precursor mechanism, dose ranges, why the bioenergetic community prefers the non-flushing form, and pairing with slow-release T3.
Mitolipin-style cardiolipin supplementation has gained attention in mitochondrial research. A research-context look at cardiolipin's role in the inner mitochondrial membrane, its connection to 3,5-T2 mitochondrial activation, dose context, and the broader Ray Peat-aligned protocol framework. Pairing with slow-release T3.
The complete research guide to methylene blue - the electron-shuttling mitochondrial cofactor that the bioenergetic-research community pairs with thyroid hormone for complete mitochondrial signaling. Mechanism via Complex IV, dose ranges, cognitive effects, and the Ray Peat-aligned protocol context.
DHEA (dehydroepiandrosterone) in the bioenergetic-research framework - mechanism, downstream metabolism, dose ranges, pregnenolone-DHEA stacking, and the Ray Peat-aligned protocol context. Pairing with slow-release T3.
The complete research guide to cyproheptadine - the first-generation H1 antihistamine and 5-HT2 serotonin antagonist that the bioenergetic-research community uses as the cleanest pharmacological anti-serotonin tool. Mechanism, dose ranges, appetite and sleep effects, pairing with thyroid hormone, and the Ray Peat context.
Cynomel and Cynoplus - the Mexican liothyronine products that became the gold-standard cheap-T3 source for the bioenergetic-research community over the 2000s and 2010s - have become harder to source consistently. Mechanism overview, the Grossman's manufacturing history, supply chain variability, and the case for sustained-release T3 (SR-T3) as the modern research-grade alternative.
Ray Peat opposed fasting on cortisol-suppression grounds. A growing subset of bioenergetic researchers argue that T3 replacement neutralizes the cortisol argument and unlocks fasting's autophagy and mitochondrial-biogenesis benefits. The mechanistic case for strategic fasting paired with sustained-release T3.